NanoGhost Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 12

Employees

  • Latest Deal Type
  • Crowdfunding

  • Investors
  • 3

NanoGhost General Information

Description

Developer of a drug-delivery technology designed to shrink the deadliest forms of cancer by precisely targeting tumors. The company's technology uses adult stem cells to transport medicine directly to the tumor site which aids in reducing tumor size in small lung carcinoma, prostate, and pancreatic cancer tumors, enabling patients suffering from cancer to reduce the pain of radiology treatments.

Contact Information

Formerly Known As
Nano Ghosts
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 12 Beni Gaon Street
  • P.O.B. 8936
  • Netanya
  • Israel
Primary Industry
Drug Delivery
Other Industries
Drug Discovery
Biotechnology
Corporate Office
  • 12 Beni Gaon Street
  • P.O.B. 8936
  • Netanya
  • Israel

NanoGhost Timeline

2022202320242025
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

NanoGhost Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Equity Crowdfunding 04-Mar-2024 Completed Pre-Clinical Trials
2. Seed Round 01-Jun-2023 Completed Pre-Clinical Trials
1. Seed Round 23-Dec-2019 $5M $5M Completed Pre-Clinical Trials
To view NanoGhost’s complete valuation and funding history, request access »

NanoGhost Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Preferred A
Preferred A1
To view NanoGhost’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

NanoGhost Patents

NanoGhost Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3222298-A1 Compositions comprising spherical particles and uses of same Pending 13-Jun-2021
EP-4355309-A1 Compositions comprising spherical particles and uses of same Pending 13-Jun-2021
US-20240279591-A1 Compositions comprising spherical particles and uses of same Pending 13-Jun-2021 C12M47/06

NanoGhost Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

NanoGhost Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Altshuler Shaham Investment House Corporation Minority
aMoon Fund Venture Capital Minority
NewGate Capital Venture Capital Minority
To view NanoGhost’s complete investors history, request access »

NanoGhost FAQs

  • When was NanoGhost founded?

    NanoGhost was founded in 2019.

  • Where is NanoGhost headquartered?

    NanoGhost is headquartered in Netanya, Israel.

  • What is the size of NanoGhost?

    NanoGhost has 12 total employees.

  • What industry is NanoGhost in?

    NanoGhost’s primary industry is Drug Delivery.

  • Is NanoGhost a private or public company?

    NanoGhost is a Private company.

  • What is NanoGhost’s current revenue?

    The current revenue for NanoGhost is .

  • How much funding has NanoGhost raised over time?

    NanoGhost has raised $6.87M.

  • Who are NanoGhost’s investors?

    Altshuler Shaham Investment House, aMoon Fund, and NewGate Capital have invested in NanoGhost.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »